Article

• Physiologic, biochemical, and pathological backgrounds of levodopa and possibilities for the future

  Oleh D. Hornykiewicz

  • Full Text (PDF)
• Double‐blind, placebo‐controlled study of levodopa therapy in Parkinson's disease

  Manfred D. Muenter

  • Full Text (PDF)
• Some “minor” aspects of parkinsonism, especially pulmonary function

  George D. Paulson, R. H. Tafrate

  • Full Text (PDF)
• Long‐term treatment of Parkinson's disease with levodopa

  John B. Campbell

  • Full Text (PDF)
• Psychiatric changes in patients treated with levodopaI. The clinical experiment

  Walter Knopp

  • Full Text (PDF)
• Double‐blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa‐induced movement disorders

  William H. Timberlake

  • Full Text (PDF)
• Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonism

  Thomas N. Chase

  • Full Text (PDF)
• Convulsive seizures and electroencephalogram changes in three patients during levodopa therapy

  Archie McPherson

  • Full Text (PDF)
• The Eaton Collaborative Study of levodopa therapy in parkinsonismA summary

  Robert E. Keenan

  • Full Text (PDF)
• Comments and Questions

  • Full Text (PDF)
• Closing Remarks

  O'Malley

  • Full Text (PDF)